Effect of child health status on parents’ allowing children to participate in pediatric research

BMC Medical Ethics

Laurent Béghin⁴  Frédéric Gottrand⁴  Dominique Deplanque³  Christian Libersa³  Stéphanie Coopman²  Stéphane Duhem¹  Dina Bert²  Ludovic Hardy²  Jérémy Vanhelst⁴ 

[1] Comité de Protection des Personnes Nord Ouest IV, Lille, France;Centre d’Investigation Clinique, CIC-PT-9301-Inserm-CH&U, Lille, 59037, France;Département de Pharmacologie, Faculté de Médecine, Université Lille Nord de France, Lille, France;Unité Inserm U995 & Université Lille Nord de France, Lille, France

关键词: Motivation;    Parents’ acceptance;    Pediatric research;    Ethics;   

Others  :  799985
DOI  :  10.1186/1472-6939-14-7

 received in 2012-09-19, accepted in 2013-02-12,  发布年份 2013

【 摘 要 】

Background

To identify motivational factors linked to child health status that affected the likelihood of parents’ allowing their child to participate in pediatric research.

Methods

Parents were invited to return their completed questionnaires anonymously to assess motivational factors and factors that might improve participation in pediatric research.

Results

Of 573 eligible parents, 261 returned the completed questionnaires. Of these, 126 were parents of healthy children (group 1), whereas 135 were parents of sick children who were divided into two groups according to the severity of their pathology, i.e., 99 ambulatory children (group 2) and 36 nonambulatory children (group 3). The main factor motivating participation in a pediatric clinical research study was “direct benefits for their child” (87.7%, 100%, and 100% for groups 1, 2, and 3, respectively). The other factors differed significantly between the three groups, depending on the child’s health status (all p < 0.05). Factors that might have a positive impact on parental consent to the participation of their child in a pediatric clinical research study differed significantly (χ² test, all p ≤ 0.04), depending on the child’s health status. The main factor was “a better understanding of the study and its regulation” for the healthy children and ambulatory sick children groups (31.2% and 82.1%, respectively), whereas this was the third factor for the nonambulatory sick children group (50%).

Conclusions

Innovative strategies should be developed based on a child’s health status to improve information provision when seeking a child’s participation in pediatric research. Parents would like to spend more time in discussions with investigators.

【 授权许可】

   
2013 Vanhelst et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Ramet J, Van den Anker J: The European Academy of pediatrics (EAP/CESP) and its demand for more clinical research. In Guide to Paediatric Clinical Research. Edited by Rose K, Naker V. CH: Basel; 2007:6-12.
• [2]Smyth R, Weindling A: Research in children, ethical and scientific aspects. Lancet 1999, 354:21-24.
• [3]Caldwell P, Murphy S, Butow SB: Clinical trials in children. Lancet 2004, 364:803-11.
• [4]Cohen E, Uleryk E, Jasuja M, Parkin PC: An absence of pediatric randomized controlled trials in general medical journals, 1985–2004. J Clin Epidemiol 2007, 60:118-23.
• [5]Stephenson T: “ Bonne année”, “gutes neues jahr” ? will 2007 be a “happy new year” for children’s medicines in Europe? Arch Dis Child 2007, 92:661-63.
• [6]Pandolfini C, Bonati M: European paediatric research and children’s therapeutic needs. A trial review. Acta Paediatr 2008, 97:1232-7.
• [7]Regulation (EC) No 1901/2006 of the European Parlament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Available at: http://eur-lex.europa.eu/LexUriServ/site/en/consleg/2006/R/02006R1901-20070126-en.pdf webcite. Published 2006. Accessed February 20, 2012
• [8]Directive 2001/20/EC of the European Parliament and of the Council (2001). Approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32001L0020:en:NOT webcite. Published 2001. Accessed April 6, 2012
• [9]European Medicines Agency ICH Topic E 6 (R1) guideline for good clinical practice. Available at: http://www.emea.europa.eu/pdfs/human/ich/013595en.pdf webcite. Published 2002. Accessed April 6, 2012
• [10]PRNewswire. Patient recruitment plays a major role in meeting clinical trial deadlines. Available at: http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-31-2005/0004097079&EDATE webcite Published 2005. Accessed April 6, 2012
• [11]Frank G: Current challenges in clinical trial patient recruitment and enrolment. Available at:http://www.socra.org/pdf/200402_Current_Challenges_Recruitment_Enrollment.pdf webcite Published 2004.Accessed September 25, 2011
• [12]Bachenheimer JF, Brescia BA: Reinventing patient recruitment. Revolutionary Ideas for clinical trial success. Gower; 2007:1-276.
• [13]Wilfond BS, Carpenter KJ: Incidental findings in pediatric research. J Law Med Ethics 2008, 36:332-340.
• [14]Lederer SE, Grodin MA: Historical overview: Pediatric experimentation. In Children as Research Subjects: Science, Ethics, and Law. Edited by Glanz LH. New York, NY: Oxford University Press; 1994:3-25.
• [15]Costello I, Long P, Wong I: Paediatric Drug Handling. London, UK: The Pharmaceutical Press; 2007.
• [16]Broome ME: Consent (assent) for research with pediatric patients. Semin Oncol Nurs 1999, 15:96-103.
• [17]National Commision for the Protection of Human Subjects of Biomedical and Behavorial Research: The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office; 1979.
• [18]Hayman RM, Taylor BJ, Peart NS, Galland BC, Sayers RM: Participation in research: informed consent, motivation and influence. J Paediatr Child Health 2001, 37:51-54.
• [19]Pende V, Choonara I, Gennery B: Recruiting children to a clinical trial. Paediatr Perinat Drug Ther 2000, 4:75-78.
• [20]Kaplan S, Brownlee S: Dying for a cure. US News World Rep 1999, 127:34-39.
• [21]Spilker B: How to improve the quality of clinical trials and their publications. Med Clin 1992, 98:303-4.
• [22]Hsu DT, Mital S, Ravishankar C, Margossian R, Li JS, Sleeper LA, Williams RV, Levine JC, McCrindle BW, Atz AM, Servedio D, Mahony L, Pediatric Heart Network Investigators: Pediatric heart network investigators rationale and design of a trial of anggiodtensin-converting enzyme in infants with single ventricle. Am Heart J 2009, 157:37-45.
• [23]Nabulsi M, Khalil Y, Makhoul J: Parental attitudes towards and perceptions of their children’s participation in clinical research: a developing-country perspective. J Med Ethics 2011, 37:420-423.
• [24]Wulf F, Krasuska M, Bullinger G: Determinants of decision-making and patient participation in peadiatrc clinical trials: a literature review. Open J Pediatr 2012, 2:2-17.
• [25]Rothmier D, Lasley MV, Shapiro GG: Factors influencing parental consent in pediatric clinical research. Pediatrics 2003, 111:1037-1041.
• [26]Tait AR, Voepple-Lewis T, Siewert M: Factors that influence parent’s decisions to consent to their child’s participation in clinical anesthesia research. Anesth Analg 1998, 86:50-53.
• [27]Varma S, Jenkins T, Wendler D: How do children and parents make decisions about pediatric clinical research? J Pediatr Hematol Oncol 2008, 30:823-828.
• [28]Brody JL, Annett RD, Scherer DG, Turner C, Dalen J: Enrolling adolescents in asthma research: adolescent, parent, and physician influence in the decision-making process. J Asthma 2009, 46:492-497.
• [29]McCormick A: Stability of the gross motor function classification system after single-event multilevel surgery in cerebral palsy. Dev Med Child Neurol 2012, 54:1073-4.
• [30]van Stuijvenberg M, Suur MH, de Vos S, Tjiang GC, Steyerberg EW, Derksen-Lubsen G, Moll HA: Informed consent, parental awareness, and reasons for participating in a randomised controlled study. Arch Dis Child 1998, 79:120-125.
• [31]Beebe TJ, Locke GR 3rd, Barnes SA, Davern ME, Anderson KJ: Mixing web and mail methods in a survey of physicians. Health Serv Res 2006, 42:1219-1233.
• [32]Ondrusek N, Abramovitch R, Pencharz P, Koren G: Empirical examination of the ability of children to consent to clinical research. J Med Ethics 1998, 24:158-165.
• [33]Tate AR, Calderwood L, Dezateux C, Joshi H: Mother’s consent to linkage of survey data with her child’s birth records in a multi-ethnic national cohort study. Int J Epidemiol 2006, 35:294-298.
• [34]Singhal N, Oberle K, Burgess E: Parents’ perceptions of research with newborns. J Perinatol 2002, 22:57-63.
• [35]Chantler TE, Lees A, Moxon ER, Mant D, Pollard AJ, Fiztpatrick R: The role familiarity with science and medicine plays in parents’ decision making about enrolling a child in vaccine research. Qual Health Res 2007, 17:311-322.
• [36]Tait AR, Voepel-Lewis T, Malviya S: Factors that influence parents’ assessments of the risks and benefits of research involving their children. Pediatrics 2004, 113:727-732.
• [37]Langley JM, Halperin SA, Mills EL, Eastwood B: Parental willingness to enter a child in a controlled vaccine trial. Clin Invest Med 1998, 21:12-16.
• [38]Emanuel EJ, Wood A, Fleischman A, Bowen A, Getz KA, Grady C, Levine C, Hammerschmidt DE, Faden R, Eckenwiler L, Muse CT, Sugarman J: Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med 2004, 141:282-291.
• [39]Barsdorf NW, Wassenaar DR: Racial differences in public perceptions of voluntariness of medical research participants in South Africa. Soc Sci Med 2005, 60:1087-1098.
• [40]Minnies D, Hawkridge T, Hanekom W, Ehrlich R, London L, Hussey G: Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting. BMC Med Ethics 2008, 30:15.
• [41]Jacobson RM, Ovsyannikova IG, Poland GA: Testing vaccines in pediatric research subjects. Vaccine 2009, 27:3291-3294.
• [42]Yates FD Jr: Ethics for the pediatrician: religion and spirituality in pediatrics. Pediatr Rev 2011, 32:e91-94.
• [43]Barakat LP, Patterson CA, Mondestin V, Chavez V, Austin T, Robinson MR, Li Y, Smith-Whitley K, Cohen R: Initial development of a questionnaire evaluating perceived benefits and barriers to pediatric clinical trials participation. Contemp Clin Trials 2012, 34:218-226.
• [44]Snowdon C, Elbourne D, Garcia J: “It was a snap decision”: parental and professional perspectives on the speed of decisions about participation in perinatal randomised controlled trials. Soc Sci Med 2006, 62:2279-2290.
• [45]Marco CA: Impact of detailed informed consent on research subjects’ participation: a prospective, randomized trial. J Emerg Med 2008, 34:269-275.
• [46]Oduro AR, Aborigo RA, Amugsi D, Anto F, Anyorigiya T, Atuguba F, Hodgson A, Koram KA: Understanding and retention of the informed consent process among parents in rural northern Ghana. BMC Med Ethics 2008, 19:12.
• [47]Chu SH, Jeong SH, Kim EJ, Park MS, Park K, Nam M, Shim JY, Yoon YR: The views of patients and healthy volunteers on participation in clinical trials: an exploratory survey study. Contemp Clin Trials 2012, 33:611-9.
• [48]Cressey D: Informed consent on trial. Nature 2012, 482:16.
• [49]Lynöe N, Sandlund M, Dahlqvist G, Jacobsson L: Informed consent: Study of quality of information given to participants in a clinical trial. BMJ 1991, 303:610-613.
• [50]Miller TL, Lipshultz SE: Association of medical school pediatric department chairs, Inc. Building a pediatric clinical research division. J Pediatr 2008, 152:1-2.
• [51]Hankard: Specificity of pediatric clinical research. Arch Pediatr 2009, 16:655-657.
• [52]Dolan LA, Sabesan V, Weinstein SL, Spratt KF: Preference assessment of recruitment into a randomized trial for adolescent idiopathic scoliosis. J Bone Joint Surg Am 2008, 90:2594-2605.
• [53]Kodish ED, Pentz RD, Noll RB, Ruccione K, Buckley J, Lange BJ: Informed consent in the childrens cancer group: results of preliminary research. Cancer 1998, 82:2467-2481.
• [54]Donovan JL, Peters TJ, Noble S, Powell P, Gillatt D, Oliver SE, Lane JA, Neal DE, Hamdy FC, ProtecT Study Group: Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). J Clin Epidemiol 2003, 56:605-609.
• [55]Margitić S, Sevick MA, Miller M, Albright C, Banton J, Callahan K, Garcia M, Gibbons L, Levine BJ, Anderson R, Ettinger W: Challenges faced in recruiting patients from primary care practices into a physical activity intervention trial. Activity Counseling Trial Research Group. Prev Med 1999, 29:277-86.
• [56]Massimo LM, Wiley TJ, Casari EF: From informed consent to shared: a developing process in paediatric oncology. Lancet Oncol 2004, 5:384-387.
• [57]Roth DE, Chan MK, Vohra S: Initial successes and challenges in the development of a pediatric resident research curriculum. J Jediatr 2006, 149:149-150.
• [58]Davies H: Optimisation of informed consent in Paediatric Trials: Best Practice Examples. In The European Forum for Good Clinical Practice Volume Autumn/Winter: 29 & 30 January 2013. Edited by Wrobel P. Brussels: Clarity Science Communication; 2012:7-8.
• [59]NCT00870649: ClinicalTrials.gov. Identifier Number for the trial: Efficacy of Vaccine Sh28GST in Association with Praziquantel (PZQ) for Prevention of Clinical Recurrences of Schistosoma Haematobium Pathology (Bilhvax). Available at: http://www.clinicaltrial.gov webcite. Published 2012. Accessed April 20, 2012
• [60]Tait AR, Voepel-Lewis T, Malviya S, Philipson SJ: Improving thge readability and processability of a pediatric informed consent document. Arch Pediatr Adolesc Med 2005, 159:347-352.
• [61]Campbell HM, Raisch DW, Sather MR, Segal AR, Warren SR, Naik R: Impact of a clinical trial information handbook on patient knowledge, perceptions, and likelihood of participation. IRB 2008, 30:6-14.
• [62]Hartling L, Wittmeier KDM, Caldwell PH, StaR Child Health: Developing evidence-based guidance for the design, conduct, and reporting of pediatric trials. Pediatrics 2012, 129:112-117.